Is MYCOF or BTI a better dividend investment in 2026?

MYCOF currently yields 151.75% with a 5% 5-year dividend growth rate. BTI yields 5.38% with 5% growth. The better choice depends on your goal: MYCOF offers higher current income.

What is the dividend yield difference between MYCOF and BTI?

MYCOF has a forward dividend yield of 151.75% ($2.00/share annually). BTI yields 5.38% ($3.15/share annually). The yield gap is 146.37 percentage points.

Home › Compare › MYCOF vs BTI

MYCOF vs BTI: Dividend Comparison 2026

MYCOF yields 151.75% · BTI yields 5.38%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MYCOF wins by $26.46M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MYCOF

● Live price

151.75%

Share price

$1.32

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26.50M

Annual income

$11,538,455.63

Full MYCOF calculator →

BTI

● Live price

5.38%

Share price

$58.47

Annual div

$3.15

5Y div CAGR

11.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$37.7K

Annual income

$2,786.64

Full BTI calculator →

Portfolio growth — MYCOF vs BTI

📍 MYCOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MYCOF	BTI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MYCOF + BTI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MYCOF pays

BTI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MYCOF

Annual income on $10K today (after 15% tax)

$12,898.33/yr

After 10yr DRIP, annual income (after tax)

$9,807,687.29/yr

BTI

Annual income on $10K today (after 15% tax)

$457.40/yr

After 10yr DRIP, annual income (after tax)

$2,368.64/yr

At 15% tax rate, MYCOF beats the other by $9,805,318.64/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MYCOF + BTI for your $10,000?

MYCOF: 50%BTI: 50%

100% BTI50/50100% MYCOF

Portfolio after 10yr

$13.27M

Annual income

$5,770,621.14/yr

Blended yield

43.50%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

MYCOF

No analyst data

Altman Z

-4888.6

Piotroski

3/9

BTI

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$40.00

-31.6% upside vs current

Range: $40.00 — $40.00

Altman Z

2.1

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MYCOF buys

BTI buys

No recent congressional trades found for MYCOF or BTI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMYCOFBTI

Forward yield	151.75% ✓	5.38%
Annual dividend / share	$2.00	$3.15 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	11.3% ✓
Portfolio after 10y	$26.50M	$37.7K ✓
Annual income after 10y	$11,538,455.63 ✓	$2,786.64
Total dividends collected	$24.54M ✓	$14.3K
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples

Year-by-year: MYCOF vs BTI ($10,000, DRIP)

Year	MYCOF Portfolio	MYCOF Income/yr	BTI Portfolio	BTI Income/yr	Gap
1← crossover	$25,875	$15,174.51	$11,299	$598.92	+$14.6K → MYCOF
2	$64,380	$36,694.66	$12,794	$703.91	+$51.6K → MYCOF
3	$154,217	$85,329.77	$14,518	$829.07	+$139.7K → MYCOF
4	$356,039	$191,027.06	$16,513	$978.64	+$339.5K → MYCOF
5	$793,132	$412,170.66	$18,827	$1,157.84	+$774.3K → MYCOF
6	$1,706,759	$858,106.90	$21,518	$1,373.12	+$1.69M → MYCOF
7	$3,552,006	$1,725,774.37	$24,657	$1,632.46	+$3.53M → MYCOF
8	$7,157,264	$3,356,617.38	$28,329	$1,945.74	+$7.13M → MYCOF
9	$13,979,354	$6,321,081.53	$32,637	$2,325.33	+$13.95M → MYCOF
10	$26,496,364	$11,538,455.63	$37,708	$2,786.64	+$26.46M → MYCOF

MYCOF vs BTI: Complete Analysis 2026

MYCOF — Stock

Noveris Health Sciences Inc. is a biotechnology company, which engages in the research, drug development, and clinical trials of psilocybin products. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.

Full MYCOF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →

📬

Get this MYCOF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MYCOF vs SCHD MYCOF vs JEPI MYCOF vs O MYCOF vs KO MYCOF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.